Menu
Home >> NIPERs

NIPERs

National Institute of Pharmaceutical Education & Research

Indian Pharma Industry has been a global leader in Generic drugs. In order to acquire leadership position in drug discovery and development and to continue to excel in the formulations, Government recognized that human resources/talent pool is very critical. Thus Government of India has set up National Institute of Pharmaceutical Education & Research (NIPER) at SAS Nagar Mohali as a registered society under the Society Registered Act 1860, Subsequently the Institute was given statutory recognition by an act of Parliament, NIPER Act, 1998 and the Institute declared as an Institute of National Importance.

During 2007-08, six new NIPERs were started at Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli with the help of Mentor Institute. Subsequently a NIPER at Madurai was approved in 2012. During 2015-16, the Finance Minister in his Budget Speech announced 3 new NIPERs for the states of Chhattisgarh, Maharashtra and Rajasthan.

NIPER Mentor Institute Academic Session Started
NIPER, Mohali - 1998
NIPER, Ahmedabad - 2007
NIPER, Guwahati Guwahati Medical College, Guwahati 2008
NIPER, Hajipur Rajendra Memorial Research Institute of Medical Science (RMRIMS-Patna) under ICMR 2007
NIPER, Hyderabad CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 2007
NIPER, Kolkata CSIR-Indian Institute of Chemical Biology, Kolkata 2007
NIPER, Raebareli CDIR-Central Drug Research Institute, Lukhnow 2008
NIPER, Madurai Under Process -
NIPER, Chhattisgarh Under Process -
NIPER, Maharashtra Under Process -
NIPER, Rajasthan Under Process -

The main objectives of NIPER are as under:-

  • Nurture and promote quality and excellence in pharmaceutical education and research:
  • Run Master's, Doctoral and post-Doctoral courses and research in pharmaceutical education
  • Develop a multi-disciplinary approach in carrying out research and training of pharmaceutical manpower ; and
  • Act as nucleus for interaction between academic and industry by undertaking sponsored and funded research as well as consultancy projects

Admission Procedure in NIPERs:

The students are selected for admission through All India Common Admission Test conducted by NIPERs, At present these NIPERs impart Ph.D. and PG level education and grant degree under the NIPER Act, 1998.

1. NIPER, MOHALI

NIPER, SAS Nagar, Mohali was initially registered as a society under the Societies Act. The faculty for the institute was appointed in 1994. In 1998, Parliament enacted National Institute of Pharmaceutical Education and Research Act, 1998. NIPER was declared as an "Institute of National Importance" under the Act of Parliament on 26th June 1998. NIPER is a member of Association of Indian Universities.

Disciplines:

The first batch of students was admitted in 1998. NIPER offers Masters'and Ph.D. degrees in 15 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Natural Products
  3. Traditional Medicine
  4. Pharmaceutical Analysis
  5. Pharmacology & Toxicology
  6. Regulatory Toxicology
  7. Pharmaceutical Technology (Biotechnology)
  8. Pharmaceutical Technology (Formulations)
  9. Pharmaceutical Technology (Process Chemistry)
  10. Pharmaceutics
  11. Biotechnology
  12. Pharmacy Practice
  13. Clinical Research
  14. Pharmacoinformatics
  15. Pharmaceutical Management

Student's details:

2017-2018
Course Enrolled Pass-out
M.S (Pharm) 247 255
Total 280 277

Academic excellence

In 2017, the Institute has published 63 articles in journals of repute (till Oct. 2017). NIPER has filed 4 patents in 2017-2018 (till Oct. 31, 2017) and 56 patents have been granted till date. Since the inception of academic programme (till Nov. 1, 2017), 2968 students have passed out (Masters 2169, MBA 529 & Ph.D. 270).

Teacher-Student ratio:-

Course Ratio
Ph. D. (S-120:F27) i.e 4.4:1
Masters' (Science) 416:27
MBA (Pharm.) 78:3

* Guest faculty members are also taking classes

Research:-

  1. Neglected diseases- Research is carried out in the areas of tuberculosis, leishmaniasis and malaria. New molecules are being synthesized and their mechanisms of action are being worked out.
  2. Other diseases Metabolic pathways in diseases like inflammation, infection, cancer, diabetes, neurodegeneration are being worked out.
  3. Drug development and formulation
    1. Improvement of oral bioavailability, synergistic anticancer efficacy and reduced toxicity of drugs has been attempted.
    2. New formulations are being developed.
  4. Other Areas
    1. Chemo-enzymatic synthesis of drugs
    2. Monograph on herbals is being developed.
    3. Study of the effect of RNA aptamers on stabilization of misfolded proteins
    4. Assessment of an appropriate and reliable method to diagnose neuropathic pain

Innovation / knowledge transfer

  1. Patents and Commercialisation: 183 (filed)/56 (granted)/08 (licensed)
  2. Research income earned from industry: Rs.20 lakh (receipts in 2017-18 till date)
  3. Citation per faculty: 798 (2016 till date)

Institution leadership

  1. Ranked #1 in the category ‘Pharmacy' in NIRF MHRD 2018 Rankings
  2. Recognized as among the top 100 Indian Innovator companies and research organizations (2014) (Thompson Reuters)
  3. Recognized as one of the four institutes in the country with AAAA+ ranking by Career360 magazine (Outlook group) (March 2014)
  4. Chosen as one of the destinations (apart from USA and UK) by Government of Kazakhstan for award of Bolashak scholarship to its nationals to pursue research programme in pharmaceutical sciences

Impact of NIPER

The success of NIPER, S.A.S. Nagar has encouraged the GoI to set up more NIPERs across the country to meet the growing demands of the pharmaceutical sector. In addition, NIPER has carried out training programmes for personnel from India and abroad under ITEC-SCAAAP, capacity building programmes (World Bank-sponsored) and SMPIC. Participation in rebuilding of public sector enterprises like IDPL, BCPL, HAL, etc. Training and analytical services provided to small and medium-scale enterprises (SMEs): Setting up of a centre for SMEs. Members of committee evaluating ‘Investigational New Drugs' (IND) applications.

2. NIPER- Ahmedabad

NIPER Ahmedabad was established in the year 2007. Since its inception, the institute was functioning under Mentor Institute B.V. Patel PERD Centre up to 31st July 2016. From 01st August, 2016 it has started functioning independently at its own campus at Palaj, Gandhinagar in temporary building with a state of art research laboratory facility including animal house. In absence of Board of Governors, Steering Committee under the Chairmanship of Secretary (Pharma), Department of Pharmaceuticals, looks after administrative work in NIPER Ahmedabad.

Discliplnes:

NIPER offers Masters' and Ph.D. degrees in 7 streams and caters to the various needs of pharmaceutical industry:

  1. Natural Products
  2. Pharmaceutics
  3. Biotechnology
  4. Medicinal Chemistry
  5. Pharmaceutical Analysis
  6. Pharmacology and Toxicology
  7. Medical Device

Students details:

2017-2018
Course Enrolled Pass-out
M.S (Pharm) 72 70
Total 85 71

Academic excellence

NIPER Ahmedabad has a Teacher-Student ratio:total of 405 M.S Pharm. students already graduated from NIPER- Ahmedabad and are well placed in various Pharma industries in India and abroad. Presently, 72 students are pursuing their M.S.(Pharm) course in different disciplines. A total of 29 students are continuing with their PhD studies, o3 students have already submitted their PhD thesis and 03 students have been awarded Ph.D. Degree. Institute has filed up till now 10 patents wherein faculty or students of NIPER-Ahmedabad are one inventors.

Teacher-Student ratio:

Presently1: 9 (19 Faculty: 170 students)

Research:

  1. Active Research Areas:

  2. Diabetes, Cancer, Neurodegenerative Disease, Infectious diseases, Tissue repair, regeneration and Medical Implants.

  3. Project:

  4. Completed : 05 Ongoing:12 (09 -National , 03 - International)

  5. Publications:

  6. 89 Total, 29 (Years 2017)

  7. Poster Presentation:

  8. 55(Year 2017)

Innovation & Knowledge transfer

03 Patent has been filed from Feb 2016 onwards.

Impact of NIPER :

NIPER Ahmedabad would serve as a good launching platform to revamp the pharma education and research, to initiate the new era of pharmaceutical and biomedical sciences. NIPER-Ahmedabad lays its commitment in building human resource for promoting research and development in the country and contribute towards ‘'Make in India'' initiative as a part of its national responsibility

3. NIPER Guwahati

NIPER Guwahati started functioning from 2008 under Mentor Institute Guwahati Medical College Guwahati, Assam (up to 31 July 2017). In the absence of Board of Governors, Steering Committee under the Chairmanship of Secretary (DoP, Govt. of India) look after administrative work in NIPER Guwahati. From 1st August 2017, NIPER-Guwahati is functioning from the NITS-Mirza Campus.

Disciplines:

NIPER Guwahati started functioning from 2008 under Mentor Institute Guwahati Medical College Guwahati, Assam (up to 31 July 2017). In the absence of Board of Governors, Steering Committee under the Chairmanship of Secretary (DoP, Govt. of India) look after administrative work in NIPER Guwahati. From 1st August 2017, NIPER-Guwahati is functioning from the NITS-Mirza Campus.

  1. Pharmacology & Toxicology
  2. Pharmacy Practice
  3. Biotechnology.

Students Details

2017-2018
Course Enrolled Pass-out
M.S (Pharm) 39 39
Ph. D. 04 Pursuing
Total 43 39

Academc excellence:

  1. Ph.Ds- 25 (enrolled), Degrees awarded - 08
  2. Total M.S. (Pharm.) (since inception), Students enrolled - 324
    Graduated - 248 (74 students are currently pursuing their P.G. courses)
  3. Among the graduated students, many of them got admission into Ph.D. programs in various National & International Universities/Institutes. Rest of the students got placed in various Pharmaceutical Industries and Consultancies viz., Novartis, Novo Nordisk, Biocon, Quintilles, etc.
  4. iv. Publications: In total, 112 research papers have been published out of which 20 articles have been published in the current year in various National and International Journals.

Teacher-Student ratio:

  • Biotechnology: 1:10
  • Pharmacology and Toxicology: 1:20
  • Pharmacy Practice: 1:10

Research:

BIOTECHNOLOGY :

Development of Biopharmaceuticals using Biomolecular Engineering/Synthetic Biology approaches -

  • Oncogenic mRNA cleaving Deoxyribozymes;
  • Development of new approaches of Immune rerouting for targeting cancer cells;
  • Development of new approaches of Immune rerouting for targeting cancer cells;
  • Generation of random Protein coding sequences & Aptamer based therapeutics and diagnostic tools.

Investigation on Genomics and Proteomics to study various diseases like Multiple Myeloma, Acute Myeloid leukemia, Chronic Myeloid leukemia, Myodisplastic syndrome, Ischemia-Stroke disorder, Neuropathic Pain, etc.

PHARMACOLOGY AND TOXICOLOGY:

  • Molecular Pharmacology;
  • Development of Cancer targeted drug delivery systems;
  • Screening Indian biodiversity and Indian Systems of Medicine in search of newer compounds in the area of inflammation, arthritis, diabetes, cancer and hepatoprotective activities;
  • Targeting RANKL for the treatment of inflammation and cancer induced bone disorders.
  • Screening of NCE's & North-East plant products for anti-Parkinson's and antidepressant effects.
  • Studies on the mitigation of drug induced toxicities through natural products derived from Northeast India.

PHARMACY PRACTICE

  1. Study of drug utilization pattern for antiepileptic and antipsychotic drugs.
  2. Impact of Lipodystrophy on Quality of Life, Social and Psychological Aspects in PLHIV on First line and Second line Anti Retroviral regimen
  3. Haemovigilance: An important tool for improving safe blood transfusion practices

Innovation & Knowledge transfer:

The institute is currently in the process of submitting one patent application in the area of Biopharmaceuticals. It will be further explored for its commercial value.

Impact of NIPER:

The establishment of NIPER-Guwahati has given a strong boost to the promotion of Pharmaceutical Education & Research in the North East region of India. Research efforts of NIPER Guwahati have revived the studies on medicinal value of local herbs of North East Region against various diseases. NIPER-Guwahati is further moving ahead in the field of Biopharmaceuticals and is the only NIPER to have a Synthetic Biology Laboratory, which is listed among the Indian Synthetic Biology labs.

4. NIPER Hajipur

NIPER Hajipur started functioning in 2007 under Mentor Institute Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna. In absence of Board of Governors, Steering Committee under the Chairmanship of Secretary (Pharma) looks after administrative work in NIPER Hajipur.

Disciplines:

NIPER offers Masters' and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry:

  1. Biotechnology
  2. Pharmacy Practice
  3. Pharmacoinformatics

Students detail:

2017-2018
Course Enrolled Pass-out
M.S (Pharm) 36 22
Ph. D. 06 Pursuing
Total 42 22

Academic excellence:-

NIPER Hajipur has awarded 286 students their Master's degree since its inception.

Teacher-Student ratio: 1:10

research

Biotechnology

  • Development of novel drugs against Kala zaar (Leishmaniasis) targeting epigenetic factors and DNA repair pathway.
  • Development of non-invasive tool for early detection of breast cancer
  • Development of Novel therapeutic strategies against HIV
  • Application of functionalized and conjugated gold Nanoparticles for improved antimicrobial efficacy

Pharmacoinformatics

  • Identification of novel inhibitors for cysteine synthase enzyme for Leishmania donovani. Using structure based pharmacophore models, Molecular dynamics studies and virtual screening methods.
  • Development of novel inhibitors for G-Protein Coupled Receptor 3(GPR3) for the treatment of Alzheimer's disease (AD) using QM docking studies, homology modelling, molecular dynamics (MD) studies, free energy calculation studies.

Pharmacy Practice

  • HPV and associated clinical outcomes in cervical cancer
  • Association among periostin, testosterone and obesity with the incidence of osteoporosis in elderly male type 2 diabetic patients
  • Assessment of sex hormones (estrogen and testosterone) in type 2 diabetes mellitus patients under oral hypoglycemic drugs
  • Assessment of periostin in post menopausal thyroid patients and finding relationship with osteoporosis
  • To evaluate the ADR of imatinib with reference to p210 and p190 fusion transcripts in chronic myloidleukemia patients.

Impact of NIPER:

NIPER Hajipur has successfully produced 286 students in three disciplines namely, Biotechnology, Pharmacoinformatics and Pharmacy Practice who are either employed in different pharmaceutical industries or pursuing their higher education in different institutes or universities across the globe. Many of NIPER Hajipur ex-students are engaged as faculty at different institutions.

5. NIPER Hyderabad

NIPER Hyderabad started functioning in 2007 under Mentorship of Institute Indian Institute of Chemical Technology, CSIR-IICT, Hyderabad. In absence of Board of Governors, Steering Committee under the Chairmanship of Secretary (Pharma) look after administrative work in NIPER, Hyderabad.

Disciplines:

NIPER offers Masters' and Ph.D. degreesin 7 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Pharmaceutical Analysis
  3. Pharmacology & Toxicology
  4. Pharmaceutics
  5. Pharmaceutical Management
  6. Pharmaceutical Technology (Process Chemistry)
  7. Regulatory Toxicology

Students details:

2017-2018
Course Enrolled Pass-out
M.S (Pharm) 121 112
Ph. D. 20 8
Total 141 120

Academic excellence:-

  • Master Students Passed Out: 707
  • Students pursuing Ph.D course: 79
  • Doctoral degree awarded: 22
  • Patents (filed): 12
  • Research Publications: 450
  • Sanctioned extramural research projects: 29

Teacher-Student ratio

Faculty: Student ratio should be 1:10, but few departments are having 1:15 ratio.

Core Research areas:

  • Integrated Drug Discovery & Product Development Programmes
    1. Cancer, Inflammation and related proliferative diseases
    2. Diabetes and other metabolic disorders
    3. Infectious diseases
    4. Psoriasis
  • In vitro and in vivo screening
  • In vitro and in vivo screening
  • Development of Analytical Methods, Impurity Profiling and Stability studies
  • Solid state characterization

Innovation / knowledge transfer

  1. Patents and commercialization- 12 patents filed in areas of Cancer Drug Discovery,Formulation Development and Analytical Method Development
  2. Research income earned from Industry - 22 Lakhs
  3. Citation per faculty- Average 320 citations per faculty

Impact of NIPER:

Creating excellent human resource by imparting high quality education and training in pharmaceutical sciences which would help the pharmaceutical industry. Serving as an excellent research institute by focusing on thrust areas of national and international relevance. Fostering academic and industrial collaborations to address some of the key issues in the pharma sector and producing pharma productive human resource professionals to cater to the needs of Pharmaceutical industry in the country.

6. NIPER Kolkata

NIPER, Kolkata is presently housed at the Indian Institute of Chemical Biology (IICB) - a premier Institute of the Council of Scientific & Industrial Research (CDRI), India, which is the Mentor Institute. In absence of Board of Governors, Steering Committee under the Chairmanship of Secretary (Pharma) looks after the administrative work of the institute.

Disciplines:

NIPER offers Masters' and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Natural Products
  3. Phamacoinformatics

Students details:

2017-2018
Course Enrolled Pass-out
M.S (Pharm) 44 44
Ph. D. 10 pursuing
Total 54 44

Academic excellence:

Since inception till date 364 students have been graduated. Among them, 247 have been engaged in different companies and academic institutions. Institute is not aware of any unemployed among NIPER-K graduates.

Teacher-Student ratio: 1:11

Research:

  1. Active Research Areas: Synthetic and plant based drug discovery, immunology and immune diagnostics, cellular and molecular biology, recombinant DNA technology and monoclonal antibody technology, novel drug delivery systems, chemical and biochemical process technology, etc.
  2. Innovation & Knowledge transfer:93 Nos. Research papers have been published in renowned international journals from the project work of the MS (Pharm.) students.

Impact of NIPER:

  1. A total of 364 highly knowledged students have been graduated.
  2. 247 students are engaged to work in companies/institutions.
  3. 35 Research papers have been published.
  4. 3 numbers of MS (Pharm.) second year students have undergone their project work in M/s Sanofi India Pvt. Limited. During their 3 months training monthly stipend were paid by the M/s Sanofi India Pvt. Ltd.
  5. M.S. (Pharm.) students of NIPER-Kolkata stood 1st & 2nd position in the National Eligibility Test for Ph.D. course admission conducted by NIPER-Mohali continuously two years 2016-17 & 2017-18

7. NIPER- RAIBARELI

NIPER-Raebareli started functioning in 2008 under the mentorship of CSIR-Central Drug Research Institute, Lucknow. In absence of Board of Governors Steering Committee under the Chairmanship of Secretary (Department of Pharmaceuticals) look after administrative work of NIPER-Raebareli.

Disciplines:

NIPER offers Masters' and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Pharmaceutics
  3. Pharmacology and Toxicology
2017-2018
Course Enrolled Pass-out
M.S (Pharm) 37 37
Ph. D. 06 pursuing
Total 43 37

Academic excellence:-

  1. Total 258 passed out since inception of the institute.
  2. Ph.D. programme in three disciplines viz. Medicinal Chemistry, Pharmaceutics and Pharmacology and Toxicology have been started from academic session 2017-18 in order to boost R&D activities in pharmaceutical sciences.
  3. Among the graduated students, many of them got selected in various Pharma industries and others have got admission in Ph.D. programs in various National & International Universities/ Institutes.
  4. (v) More than 40 papers have been published in various reputed National and International Journals.

Teacher-Student ratio

Course Ratio
Ph. D. 1:1
M.S (Pharm) 1:15

Research

The various R & D activities currently in progress and/or planned at NIPER, Raebareli are as follows-

  • Created excellent human resource by imparting high quality education in pharmaceutical sciences.
  • Served as an excellent research institute by focusing on thrust areas of national and international relevance.
  • Faculty have published research papers and reviews and also chapters in books in highly rated journals and international publications like Elsevier/ Springer etc.
National Institute of Pharmaceuticals Education and Research (NIPERs) Contact List
S.No. Responsibility Centers and Subordinate Landline Number Email Mobile Number Address
1. Prof. A. Raghuram Rao Director) 0172-2214690 0172-2214697 director[at]niper[dot]ac[dot]in 08790432456 SAS Nagar, NIPER Mohali,Punjab - 160062
2. Dr. Kiran Kalia, (Director) 079-66745555 kirankalia[at]gmail[dot]com 9714618573 Palaj Opp. Air Force Station Head Quarter, Gandhinagar-382355, Gujarat.
3. Dr. Shashi Bala Singh(Director) 040-23073740 director[dot]niperhyd[at]gov[dot]in 09999297992 NIPER, Hyderabad IDPL Township, Balangar, Hyderabad-500007
4. Dr. Pradeep Das, (Project Director) 0612-2631565 drpradeep[dot]das[at]gmail[dot]com 09431012380 E.P.I.P. Campus, Industrial Area, Hajipur-844102, Bihar
5. Dr.V. Ravichandiran, (Director) 033-24995803 033-23200086 vishnuvardhr[at]gmail[dot]com director[at]niperkolkata[dot]edu[dot]in 09443963481 Indian Institute of Chemical Biology (IICB, under CSIR), Mentor Institute for NIPER-Kolkata 4, Raja S.C. Mullick Road, Jadavpur, KOLKATA-700 032 (W.B.)
6. Dr. USN Murty (Director) 0361-2132751 murtyusn[at]gmail[dot]com murty_usn[at]yahoo[dot]com 0912706998 C/o NITS-Mirza Santipur, Parlli Part, NH-37 Mirza, Kamrup, Assam - 781 125
7. Dr. SJS Flora (Director) 0535-2700851 sjsflora[at]hotmail[dot]com 09425482305 Shree Bhawani Paper Mill Road, ITI compound, Raebareli U.P. - 229010
English
Min Description: 
Nurturing Quality & Excellence in Pharma Education and Research